Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion
Xuemei Gu(Shanghai Eighth People Hospital), Ping Gao(University of Science and Technology of China), Mengqiu Yuan(University of Science and Technology of China), Chuxu Zhu(South China University of Technology), Yingxuan Yu(South China University of Technology), Zhenhua Bian(South China University of Technology), Pinggen Zhang(University of Science and Technology of China), Linchong Sun(University of Science and Technology of China), Caixia Suo(Guangzhou First People's Hospital), Jin‐Zhi Du(South China University of Technology), Haoran Wei(First Hospital of China Medical University), Liang Chen(Shanghai Jiao Tong University), Huafeng Zhang(University of Science and Technology of China), Kai Yan(Guangdong Academy of Medical Sciences), Zhikun Li(South China University of Technology), Shengqi Shen(University of Science and Technology of China)
Cited by 73
Related Papers
Metabolic reprogramming and epigenetic modifications on the path to cancer
|Protein & Cell|2021|737
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions
|Cell Research|2015|316
ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1
|Nature Cancer|2021|203
Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1
|Nature Communications|2014|187